Ministry health

New COVID-19 cases – Weekly review: November 29 – December 5

The number of people who tested positive for COVID-19 rose from 2,373 to 2,699 cases (+ 14%) for the week of November 29 to December 5.

Among the 2,699 new infections, the incidence rate of positive unvaccinated persons is 662.67 per 100,000 inhabitants and 305.48 per 100,000 inhabitants for those who had a complete vaccination schedule.

Note that unvaccinated people are more than twice as likely become infected as people with a complete vaccination schedule.

Among the hospitalizations, 24 out of 50 patients in normal care were not vaccinated (26 had a complete vaccination schedule), while 8 out of 16 in intensive care were not vaccinated.

The number of PCR tests performed during the week of November 29 to December 5 increased from 27,439 to 30,268.

35 people reported a positive rapid antigen test (RAT) for report week, up from 60 the week before, bringing the number of positive results performed by a health worker to a total of 576. Since the introduction of self-tests , 804 positive results were reported (with 0 cases for the week of November 29 to December 5). It should be noted that positive RATs are not included in the calculation of the positivity rate.

As of December 5, the number of active infections rose to 5,098 from 4,269 on November 28, while the number of people cured rose from 83,967 to 85,726. The average age of people diagnosed with COVID-19 positive decreased slightly, from 33.4 to 33.2 years.

For the week of November 29 to December 5, 11 new COVID-19-related deaths were reported. The average age of the deceased is 84 years old.

In hospitals, there were 50 new admissions of confirmed COVID-19 patients in normal care, up from 43 the previous week. In intensive care, the number of occupied beds has increased from 11 to 16. The average age of patients has increased from 58 to 64 years.

Positivity rate and incidence rate

For the reference period, the effective reproduction rate (R) decreased, with 1.03% against 1.16% the previous week, while the positivity rate on all the tests carried out (prescriptions, contact tracing ) decreased from 8.65% to 8.92%.

The 7-day incidence rate rose to 425 per 100,000 inhabitants, compared to 374 per 100,000 inhabitants the previous week.

Compared to the previous week, the incidence rate increased in all age groups except the 75 and over age group (-14%). The largest increase was recorded in the 15-29 age group (+ 22%), followed by the 60-74 age group (+ 14%). The highest incidence rate is recorded in the 0-14 age group with 758 cases per 100,000 inhabitants. The lowest incidence rate is recorded in the age group 75 years and over, with 147 cases per 100,000 inhabitants.

Quarantine and isolation

During the week of November 29 to December 5, 5,066 people were in isolation (+ 25%) and 8,760 in quarantine (+ 9%).

Contamination

For the 2,699 new cases (recorded between November 29 and December 5, 2021), family circle remains the most frequent source of transmission of COVID-19 infections with 36.3%, followed by education (19 , 0%), mainly in primary education (13.9%). ), work (7.4%) and leisure (5.0%). The percentage of undetermined sources increased (27.3%).

Scenario 4 at Mersch Primary School

On November 25, 1 student tested positive in a class in cycle 3.2. In the same class, 4 other students tested positive on November 28 and 2 on November 29. The class is quarantined until December 3.

In addition, a high number of positive cases appeared at the “Raoul Follereau” school center in Koetschette and at the primary school in Redange. The situation is being watched closely.

Vaccinations: update

For the week of November 29 to December 5, a total of 32,959 doses were administered. 3,530 people received a 1st dose, 3,398 a 2nd dose and 26,031 people received a complementary dose to a full vaccination, bringing the total number of vaccines given on December 7 to 940,551.

434,615 people have a complete vaccination schedule, which corresponds to a vaccination rate of 78.6% of the eligible population (i.e. the 12+ population).

Booster dose: Temporary reopening of a fourth vaccination center in the LAR hangar in Findel

In order to offer all those affected by a COVID-19 booster vaccine an additional possibility of being vaccinated, the Government has decided to temporarily reopen the Luxembourg Air Rescue (LAR) vaccination center in Findel. The LAR vaccination center will open its doors this Friday, December 10. Details of the opening hours are available on www.covidvaccination.lu.

It should be noted that the vaccination center will be used exclusively for the administration of booster doses by appointment.

The booster dose can of course be administered, without any invitation from the Government, by the general practitioner or at a “Pop Up” vaccination point.

Pop Up vaccination: “Lëtzebuerg léisst sech impfen”

To increase vaccination coverage, the Government has decided to facilitate access to vaccination by deploying temporary vaccination points (“Pop Up” vaccination) and mobile teams will be present in high traffic areas (pedestrian areas, shopping centers. , events organized by certain municipalities).

The list of all new vaccination spots, constantly enriched and updated, can be consulted on the site www.covidvaccination.lu.

IMPF’O’DAY – “Lët’z talk about vaccination”: B2B AND B2C conference-debate on vaccination against COVID-19

As part of Immunization Week (“Impfwoch”), the Ministry of Health is organizing the IMPF’O’DAY on Saturday 11 December to European Congress Center (ECCL). The day will consist of two conference-debates bringing together various health experts who will address the theme of vaccination against COVID-19 and answer questions from the public.

The morning conference will be for people working in the health sector, while the afternoon conference will be for the general public.

Among the invited experts for both conferences are Dr Charles Benoy, Dr Thomas Dentzer, Christophe Dohm (Nurse), Dr Isabel De La Fuente Garcia, Dr Claude Muller, Dr Jean-Claude Schmit (Director of Health ), Dr Gérard Schockmel and Annick Schons (nurse).

Please note that participation in the conferences is free.

For more information on the conference-debates please visit this link: https://impfen.lu/impfoday/

Incidence rate of people who test positive based on vaccination status reported since December 6

The COVID-19 monitoring system in place in Luxembourg is constantly adapted to produce indicators reflecting the evolution of the epidemic in real time.

As of December 6, 2021, incidence rates of new infections by vaccination status are included in daily reports. These new infections only affect people who test positive by PCR test. Consequently, an adaptation of the key indicators of the daily report will be implemented on that date on www.covid19.public.lu.

The Excel file of the incidence rates of people who test positive according to vaccination status will be put online every Friday at the end of the day on the site www.data.public.lu.

The evolution of variants

The variant sequencing data are published every Friday on the website of the National Health Laboratory (LNS) https://lns.lu/en/departement/department-of-microbiology/revilux/.

Monitoring of wastewater in Luxembourg within the framework of SARS-CoV-2

The level of contamination of the 13 sampled wastewater treatment plants studied by LIST (Luxembourg Institute of Science and Technology) during the week of November 29 to December 5 showed a still high prevalence of SARS-CoV-2 in wastewater. on a national level. This week’s results show a flow of SARS-CoV-2 similar to last week, with the signal stabilizing at a high level. A similar trend is also observed at the regional level for most of the wastewater treatment plants analyzed, without regional disparities.

All CORONASTEP reports are available on the LIST website: https://www.list.lu/fr/covid-19/coronastep/

Press release from the Ministry of Health, the Ministry of National Education, Children and Youth, the National Health Laboratory (LNS) and the Luxembourg Institute of Science and Technology (LISTING)